Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Glioblastoma 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2 Glioma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1

Interventions

Paclitaxel 19 pembrolizumab 16 Carboplatin 12 Bevacizumab 7 lenvatinib 6 rucaparib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 Gemcitabine 4 Cisplatin 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Trastuzumab 2 Taxes 2 Radiotherapy, Intensity-Modulated 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡